Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone therapy versus primary surgery in symptomatic chronic subdural hematoma (DECSA Trial)
2015-001563-39Phase 4Terminated
- Sponsor
- Haaglanden Medical Centre
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in Chronic subdural haematoma (CSDH) (2 arms), sponsored by Haaglanden Medical Centre. Primary endpoint: Functional outcome at 3 months (modified Rankin Scale). Started Feb 2016; status: terminated.
02
Drugs
dexamethasone
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on 2015-001563-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001563-39.